ETON PHARMACEUTICALS INC
ETON·29772L108·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
ETON (ETON PHARMACEUTICALS INC) is held by 65 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($42.4M), VANGUARD CAPITAL MANAGEMENT LLC ($24.5M), GEODE CAPITAL MANAGEMENT, LLC ($14.3M). Net institutional sentiment: Mixed.
65
Holders
Avg rating(16 Elite)
$186.9M
Total Value
53% (74)
Fund Consensus
36 buying - 32 selling
Who's Trading
InsiderGRGruber James R.Sell $42KAug 20, 2025
InsiderGRGruber James R.Sell $632KAug 19, 2025
InsiderKDKrempa DavidSell $151KJun 16, 2025
InsiderKDKrempa DavidSell $100KJun 13, 2025
InsiderKDKrempa DavidSell $253KJun 12, 2025
13F: Insider & Congress:
Showing 1-20 of 74
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer